Schizophrenia News and Research

Latest Schizophrenia News and Research

Clinical study results on bifeprunox for schizophrenia

Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, at the 2007 annual meeting of the American Psychiatric Association.

24 May 2007

Check and balance for neuron activity provides insight into schizophrenia, seizures

Two genes important for human development and implicated in cancer and schizophrenia also help keep a healthy balance between excitation and inhibition of brain cells, researchers say.

24 May 2007

Lupin receives FDA approval for Ziprasidone Hydrochloride capsules

Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.

24 May 2007

Iloperidone shows promise for Akathisia

According to study results presented at the 2007 American Psychiatric Association annual meeting, iloperidone, an investigational atypical antipsychotic, was shown to have a favorable akathisia profile.

24 May 2007

Novel device helps monitor mental illness

Psychiatric researchers at the University of California, San Diego (UCSD) School of Medicine will report important new findings from a study of patients with bipolar affective disorder and schizophrenia at the upcoming meeting of the Society of Biological Psychiatry, to be held in San Diego May 17-20.

17 May 2007

Chemical maps hint at drug's effects on schizophrenia

Antipsychotic drugs do most of their work in the brain, but they also leave behind in the bloodstream a trail of hundreds of chemicals that may be used in the future to direct better treatment for schizophrenia and other psychiatric conditions, say Duke University Medical Center researchers.

16 May 2007

New insight into the lives of children and young people who live with, and help care for, their mentally ill parents

A new study by Loughborough University has highlighted what caring for a parent with serious mental health problems is like through the eyes of children and young people themselves.

16 May 2007

The Phi Complex as a neuromarker of human social coordination

Researchers from Florida Atlantic University (FAU) have been able to identify neural signatures of effective, real-time coordination between people in one of the first studies in the field of social neuroscience to actually record, measure and analyze both behavior and brain activity simultaneously in two interacting humans.

16 May 2007

Electroconvulsive therapy helps patients with severe depression who don't respond to other treatments

Electroconvulsive therapy has been shown to be a highly effective, safe, and even life-saving treatment for persistent and severe depression, bipolar disorder, and schizophrenia.

8 May 2007

Increasing SUMO protein in brain could be a way of treating epilepsy and schizophrenia

The brain contains about 100 million nerve cells, each having 10,000 connections to other nerves cells. These connections, called synapses, chemically transmit the information that controls all brain function via proteins called receptors. These processes are believed to be the basis of learning and memory.

7 May 2007

Study of damaged gene gives insight into causes of mental illness

Scientists have pinpointed how different types of damage in types of damage to the same gene can cause some people to suffer from schizophrenia while others have major depression.

4 May 2007

Gene malfunctions cause schizophrenia, depression symptoms in mice

Researchers have demonstrated for the first time that malfunction of a gene that had been associated with schizophrenia and depression does indeed cause symptoms of those disorders.

4 May 2007

New compounds show potential for cognitive disorders

UC Irvine researchers have identified a new class of compounds that could be used for drugs to treat cognitive disorders that accompany schizophrenia, Alzheimer's disease and ADHD, according to an article published today in the online version of the Proceedings of the National Academy of Sciences.

2 May 2007

INVEGA granted positive opinion recommending approval in Europe

Janssen-Cilag International NV has announced that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA (paliperidone prolonged release tablets).

30 Apr 2007

FDA approves INVEGA treatment for schizophrenia

The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.

30 Apr 2007

Heavy use of cannabis triggers psychotic illnesses

Scientists in the UK say the heavy consumption of the drug cannabis may trigger psychotic illnesses such as schizophrenia.

30 Apr 2007

Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure

In a first-of-its-kind study on humans, researchers measured how dopamine-related drugs affect the striatum, a part of the brain that is stimulated by rewards.

27 Apr 2007

Report identifies schizophrenia patients likely to receive depot medication

A report in the April 2007 issue of Psychiatric Services has identified a unique subgroup of schizophrenia patients in the United States who tend to receive depot antipsychotic medications.

26 Apr 2007

Psychotherapeutic drug spending surges

Spending on prescription drugs to treat depression, anxiety, pain, schizophrenia and other conditions climbed from $7.9 billion in 1997 to $20 billion in 2004 - over a 150 percent increase, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

25 Apr 2007

Swedish Big Brother behind lobotomies in the 1940s and 1950s

Sweden was more accepting than the U.S. in its attitude toward lobotomy in the 1940s and 1950s. A possible explanation for this may be the strength of paternalism in Sweden, that is, a greater tendency to make decisions on behalf of the patient in Swedish medical culture than in its American counterpart. This is according to Kenneth Ogren from Umea University in Sweden.

25 Apr 2007